SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced the appointment of Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Romano, based in the United States, brings more than two decades of finance leadership experience in the medical technology and life sciences sectors. She will help lead the company's financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations.
SS Innovations develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
This appointment is significant as SSII seeks to strengthen its financial leadership to support key milestones, particularly obtaining FDA clearance for the SSi Mantra system. Romano's track record of raising capital and managing financial operations in the medtech space suggests she is well-suited to guide the company through regulatory and commercial challenges. The company's focus on affordability and accessibility positions it to compete in the growing robotic surgery market, which is increasingly adopting minimally invasive techniques. Romano's experience at Vicarious Surgical, another player in the surgical robotics field, may provide insights into navigating competitive dynamics and investor expectations.
The full press release is available at https://ibn.fm/pAqlP. For more information about SS Innovations and its technologies, please refer to the company's website. This announcement underscores the company's commitment to expanding its global footprint and advancing surgical robotics accessibility.
